Kevin Molloy

1.7k total citations
44 papers, 1.2k citations indexed

About

Kevin Molloy is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Kevin Molloy has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 12 papers in Epidemiology and 11 papers in Oncology. Recurrent topics in Kevin Molloy's work include Cutaneous lymphoproliferative disorders research (9 papers), Cystic Fibrosis Research Advances (8 papers) and Global Cancer Incidence and Screening (6 papers). Kevin Molloy is often cited by papers focused on Cutaneous lymphoproliferative disorders research (9 papers), Cystic Fibrosis Research Advances (8 papers) and Global Cancer Incidence and Screening (6 papers). Kevin Molloy collaborates with scholars based in Ireland, United States and United Kingdom. Kevin Molloy's co-authors include Noel G. McElvaney, Catherine M. Greene, Daniel G. Petereit, Petra Helbig, Kristin Cina, B. Ashleigh Guadagnolo, Emer P. Reeves, Kerstin Pohl, E. Francis Cook and Tomás P. Carroll and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Kevin Molloy

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Molloy Ireland 15 466 323 243 240 132 44 1.2k
Liping Huang United States 18 230 0.5× 410 1.3× 215 0.9× 191 0.8× 57 0.4× 72 1.4k
Karen M. Linklater United Kingdom 23 448 1.0× 680 2.1× 119 0.5× 124 0.5× 119 0.9× 38 1.4k
Yang Zheng China 15 182 0.4× 163 0.5× 163 0.7× 70 0.3× 70 0.5× 48 857
April Camilla Roslani Malaysia 18 145 0.3× 522 1.6× 438 1.8× 83 0.3× 67 0.5× 57 1.3k
Rama Jayaraj Australia 20 119 0.3× 302 0.9× 398 1.6× 365 1.5× 79 0.6× 94 1.2k
Meriem Khyatti Morocco 19 54 0.1× 346 1.1× 184 0.8× 133 0.6× 137 1.0× 58 999
Elena Matos Argentina 19 179 0.4× 500 1.5× 359 1.5× 382 1.6× 149 1.1× 37 2.6k
Christopher A Lamb United Kingdom 26 178 0.4× 171 0.5× 384 1.6× 54 0.2× 80 0.6× 71 1.7k
Dana M. Chase United States 26 131 0.3× 564 1.7× 674 2.8× 159 0.7× 140 1.1× 115 2.3k
Mohit Girotra United States 19 292 0.6× 211 0.7× 304 1.3× 33 0.1× 57 0.4× 108 1.1k

Countries citing papers authored by Kevin Molloy

Since Specialization
Citations

This map shows the geographic impact of Kevin Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Molloy more than expected).

Fields of papers citing papers by Kevin Molloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Molloy. The network helps show where Kevin Molloy may publish in the future.

Co-authorship network of co-authors of Kevin Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Molloy. A scholar is included among the top collaborators of Kevin Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Molloy. Kevin Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonnell, Nolan, et al.. (2025). Septic shock and purpura fulminans secondary to Streptococcus pneumoniae bacteraemia in an immunocompetent individual. BMJ Case Reports. 18(3). e263010–e263010.
2.
Molloy, Kevin, Stefanie Porkert, Anne‐Marie Tobin, et al.. (2025). The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 23(9). 1094–1102.
3.
Keane, Joseph, et al.. (2025). Atypical waves: nonsporotrichoid Mycobacterium marinum skin infection in an immunocompromised scuba diver. Skin Health and Disease. 5(6). 470–473.
4.
5.
Ortiz‐Romero, Pablo L., Y. H. Kim, Kevin Molloy, et al.. (2024). Health‐related quality of life in cutaneous T‐cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome. Journal of the European Academy of Dermatology and Venereology. 39(4). 833–845. 1 indexed citations
6.
Carroll, Tomás P., et al.. (2023). CPC01 A puzzling panniculitis. British Journal of Dermatology. 188(Supplement_4).
7.
Salim, Asad, et al.. (2022). Mondor disease: an uncommon complication in dermatological surgery. Clinical and Experimental Dermatology. 48(2). 137–138.
8.
McKiernan, Paul J., et al.. (2021). miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes. Frontiers in Genetics. 12. 739311–739311. 3 indexed citations
9.
Franciosi, Alessandro N., Brian D. Hobbs, Oliver J. McElvaney, et al.. (2020). Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 202(1). 73–82. 28 indexed citations
10.
Molloy, Kevin, et al.. (2020). Real‐world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sézary syndrome. British Journal of Dermatology. 184(5). 978–981. 4 indexed citations
11.
Shamdas, Mohith, Kevin Molloy, Shireen Velangi, et al.. (2019). Conjunctivitis due to Dupilumab Treatment in Atopic Dermatitis: Clinical features and impact on gut microbiome. Investigative Ophthalmology & Visual Science. 60(9). 6712–6712. 1 indexed citations
12.
Molloy, Kevin. (2016). Tradition, memory and the culture of Irish-Australian identity, 1900-1960. 16. 47. 1 indexed citations
13.
Mirković, Bojana, Michelle Murray, Gillian Lavelle, et al.. (2015). The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. American Journal of Respiratory and Critical Care Medicine. 192(11). 1314–1324. 99 indexed citations
14.
Oglesby, Irene, Sebastian Vencken, Raman Agrawal, et al.. (2015). miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. European Respiratory Journal. 46(5). 1350–1360. 62 indexed citations
15.
Mirković, Bojana, Gillian Lavelle, Ahmed Abdul Azim, et al.. (2015). The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis. Journal of Allergy and Clinical Immunology. 137(2). 436–443.e9. 42 indexed citations
16.
Molloy, Kevin, Craig P. Hersh, Valerie B. Morris, et al.. (2014). Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes. American Journal of Respiratory and Critical Care Medicine. 189(4). 419–427. 118 indexed citations
17.
McKiernan, Paul J., Kevin Molloy, Sally‐Ann Cryan, Noel G. McElvaney, & Catherine M. Greene. (2014). Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium. The International Journal of Biochemistry & Cell Biology. 52. 184–191. 46 indexed citations
18.
Molloy, Kevin. (2010). 'Cheap Reading for the People' : Jeremiah Moore and the Development of the New South Wales Book Trade, 1840-1883. 34(4). 216.
19.
Guadagnolo, B. Ashleigh, Kristin Cina, Petra Helbig, et al.. (2009). Medical Mistrust and Less Satisfaction With Health Care Among Native Americans Presenting for Cancer Treatment. Journal of Health Care for the Poor and Underserved. 20(1). 210–226. 138 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liping Huang Breakdown of academic impact, for papers by Karen M. Linklater Breakdown of academic impact, for papers by Yang Zheng Breakdown of academic impact, for papers by April Camilla Roslani Breakdown of academic impact, for papers by Rama Jayaraj Breakdown of academic impact, for papers by Meriem Khyatti Breakdown of academic impact, for papers by Elena Matos Breakdown of academic impact, for papers by Christopher A Lamb Breakdown of academic impact, for papers by Dana M. Chase Breakdown of academic impact, for papers by Mohit Girotra
Rankless by CCL
2026